Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

CYPRESS BIOSCIENCE INC (CYPB) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/08/2012 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2011 SC 13G/A MAVERICK CAPITAL LTD reports a 0% stake in CYPRESS BIOSCIENCE, INC.
02/14/2011 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/11/2011 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals
02/04/2011 SC 13G/A CYPRESS BIOSCIENCE INC reports a 7% stake in CYPRESS BIOSCIENCE INC
01/19/2011 EFFECT Form EFFECT - Notice of Effectiveness
01/19/2011 EFFECT Form EFFECT - Notice of Effectiveness
01/19/2011 EFFECT Form EFFECT - Notice of Effectiveness
01/19/2011 EFFECT Form EFFECT - Notice of Effectiveness
01/13/2011 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
01/06/2011 SC TO-T/A Form SC TO-T - Tender offer statement by Third Party [amend]
01/04/2011 MW FTC Grants Early Termination of Waiting Period Under Hart-Scott-Rodino Act
12/29/2010 4 KRANZLER JAY D (CEO) has filed a Form 4 on CYPRESS BIOSCIENCE INC
Txns: Exercised 25,000 shares @ $3.25, valued at $81.3k
Sold 25,000 shares @ $6.46, valued at $161.5k
Exercised 25,000 options to buy @ $3.25, valued at $81.3k
12/29/2010 4 KRANZLER JAY D (CEO) has filed a Form 4 on CYPRESS BIOSCIENCE INC
Txns: Exercised 152,464 shares @ $3.25, valued at $495.5k
Sold 152,464 shares @ $6.45, valued at $983.4k
Exercised 152,464 options to buy @ $3.25, valued at $495.5k
12/23/2010 SC 13D CYPRESS BIOSCIENCE INC reports a 9.9% stake in CYPRESS BIOSCIENCE, INC.
12/22/2010 8-K Quarterly results
12/21/2010 4 Srinivas Rao (Chief Scientific Officer) has filed a Form 4 on CYPRESS BIOSCIENCE INC
Txns: Sold 7,500 shares @ $6.44, valued at $48.3k
Exercised 7,500 options to buy @ $4.75, valued at $35.6k
12/21/2010 SC TO-T/A Form SC TO-T - Tender offer statement by Third Party [amend]
12/20/2010 SC 13D/A CYPRESS BIOSCIENCE INC reports a 9.9% stake in Cypress Bioscience, Inc.
12/16/2010 8-K Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Financial Statements and Ex...
Docs: "Agreement and Plan of Merger, by and among Cypress Bioscience, Inc., Ramius Value and Opportunity Advisors LLC, Royalty Pharma US Partners, LP, Royalty Pharma US Partners 2008, LP, RP Investment Corp. and Ramius V&O Acquisition LLC",
"Amendment No. 1 to Rights Agreement, by and among Cypress Bioscience, Inc. and American Stock Transfer & Trust Company, LLC, as rights agent"
12/15/2010 SC TO-T/A Form SC TO-T - Tender offer statement by Third Party [amend]
12/15/2010 8-K Form 8-K - Current report
12/15/2010 BW Cypress Bioscience Agrees To Be Acquired by Ramius LLC and Royalty Pharma for $6.50 Per Share in Cash
12/14/2010 SC TO-T/A Form SC TO-T - Tender offer statement by Third Party [amend]
12/10/2010 SC TO-T/A Form SC TO-T - Tender offer statement by Third Party [amend]
12/10/2010 BW Cypress Bioscience Board of Directors Confirms Receipt of Revised Ramius LLC Offer in Connection with Strategic Review Process
11/09/2010 10-Q Quarterly Report for the period ended September 30, 2010
11/09/2010 8-K Form 8-K - Current report
11/09/2010 MW Cypress Bioscience Announces Third Quarter 2010 Financial Results
11/03/2010 MW Cypress Bioscience, Inc. to Present at Oppenheimer 21st Annual Healthcare Conference
10/12/2010 SC TO-T/A Form SC TO-T - Tender offer statement by Third Party [amend]
10/08/2010 8-K Form 8-K - Current report
09/30/2010 SC 13D/A CYPRESS BIOSCIENCE INC reports a 2.6% stake in Cypress Bioscience, Inc.
09/28/2010 MW Cypress Bioscience Board of Directors Unanimously Rejects Ramius' Unsolicited Tender Offer
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy